Physicians with current and valid licenses in the United States, Canada, or Mexico who read any 3 of the selected continuing medical education (CME) articles in this issue of Archives of Neurology, complete the CME Evaluation Form, and fax it to the number or mail it to the address at the bottom of the CME Evaluation Form are eligible for category 1 CME credit. There is no charge.
The American Medical Association (AMA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. The AMA designates this educational activity for up to 3 hours of category 1 CME credit per Archives of Neurology issue toward the AMA Physician's Recognition Award (PRA). Each physician should claim only those hours of credit that were actually spent in this educational activity.
Physicians with current and valid licenses in the United States, Mexico, or Canada are eligible for CME credit even if they live or practice in other countries. Physicians licensed in other countries are also welcome to participate in this CME activity. However, the PRA is only available to physicians licensed in the United States, Canada, or Mexico.
The Archives of Neurology provides new evidence for the practice of neurology, neurosurgery, and other specialties whose goal is to improve the neurological health of all people. Original contributions, neurological reviews, neurology and public health, and history of neurology are among the categories of articles published, but all contributions receive a sympathetic reading by the Chief Editor. The journal's editorial board sets the initial framework for the types of articles published, which is then modified by feedback from editors, external peer reviewers, authors, and readers. We are keen to receive submissions from practicing neurologists to provide new insight for colleagues.
We want our readers to assess each article critically; this CME activity is active, not passive. Does the article contribute in some way to the practice of neurology? How could you modify your practice style to incorporate what you have learned? How can you acquire more information, challenge the authors' conclusions, or verify what you have read? Which of the articles in each issue is least helpful in your quest for the best and most applicable evidence?
To earn 1 hour of category 1 CME credit, you should read any 3 of the CME articles listed and complete the CME Evaluation Form on the page following the listing of CME articles listed below. To earn 3 hours of credit, read all of the articles listed below and complete the CME Evaluation Form. The CME Evaluation Form must be submitted within 4 weeks of the issue date. A certificate awarding up to 3 hours of category 1 CME credit will be faxed or mailed to you; it is then your responsibility to maintain a record of credit received. Questions about CME credit processing should be directed to The Blackstone Group; tel: (312) 419-0400, ext 225; fax: (312) 269-1636.
One of our goals is to assess continually the needs of our readers so we may enhance the educational effectiveness of the Archives of Neurology. To achieve this goal, we need your help. You must complete the CME Evaluation Form to receive credit.
The articles listed below may be read for CME credit.
Age-Related Memory Decline: Current Concepts and Future Directions
Educational Objective: To review the effects of age on memory and brain function.
Glutamate Transporters in Neurologic Disease
Educational Objective: To understand the role of glutamate transporters in neurologic disease.
Evaluation of CSF-tau and CSF-Aβ42 as Diagnostic Markers for Alzheimer Disease
Educational Objective: To learn if there are useful cerebrospinal fluid biomarkers for Alzheimer disease.
Frequency of Tau Gene Mutations in Non-Alzheimer Dementia
Educational Objective: To determine the frequency of tau mutations in dementia that are not are a result of vascular or Alzheimer pathologic conditions.
Ratio of 8-Hydroxyguanine in Intact DNA to Free 8-Hydroxyguanine Is Increased in Alzheimer Disease Ventricular Cerebrospinal Fluid
Educational Objective: To examine markers of oxidative stress in cerebrospinal fluid of individuals with Alzheimer disease.
Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Educational Objective: To recognize that mild cognitive impairment indicates early Alzheimer disease.
Mild Cognitive Impairments Predict Dementia in Nondemented Elderly Patients
Educational Objective: To realize that global cognitive impairments, but not memory loss alone, increase the risk of dementia.
Response of Patients With Alzheimer Disease to Rivastigmine Treatment
Educational Objective: To understand the relationship between Alzheimer disease progression rate and response to rivastigmine.
Study of Donepezil in Patients With Alzheimer Disease
Educational Objective: To examine the efficacy and safety of donepezil in Alzheimer disease.
Postmenopausal Estrogen Replacement Therapy and the Risk of Alzheimer Disease
Educational Objective: To evaluate the relationship between postmenopausal estrogen replacement therapy and Alzheimer disease.
Amyloid Precursor Protein in Platelets of Patients With Alzheimer Disease
Educational Objective: To determine whether acetylcholinesterase inhibitor therapy modifies the ratio of amyloid precursor protein forms in Alzheimer disease.
A Method for Estimating Progression Rates in Alzheimer Disease
Educational Objective: To learn whether disease progression rate in Alzheimer disease can be predicted.
Alterations of Striatal Dopamine Receptor Binding in Alzheimer Disease Are Associated With Lewy Body Pathology and Antemortem Psychosis
Educational Objective: To understand the relationship of altered striatal dopamine receptor binding and Lewy bodies and psychosis in Alzheimer disease.
Factors Associated With Incident Human Immunodeficiency Virus–Dementia
Educational Objective: To identify risk factors for HIV dementia.
The Effect of Brain Atrophy on Cerebral Hypometabolism in the Visual Variant of Alzheimer Disease
Educational Objective: To understand the significance of cerebral metabolic lesion distribution in the visual variant of Alzheimer disease.
Neuronal Cyclooxygenase 2 Expression in the Hippocampal Formation as a Function of the Clinical Progression of Alzheimer Disease
Educational Objective: To recognize that neuronal cyclooxygenase 2 may be an indicator of progression in Alzheimer disease.
Frontal Lobe Hypometabolism Predicts Cognitive Decline in Patients With Lacunar Infarcts
Educational Objective: To learn that cognitive decline with lacunes may reflect the neuropathology of subcortical frontal circuits.
Physical Activity and Risk of Cognitive Impairment and Dementia in Elderly Persons
Educational Objective: To realize that regular physical activity may protect elderly people from dementia.
Dementia With Lewy Bodies Studied With Positron Emission Tomography
Educational Objective: To evaluate the role of positron emission tomography in the diagnosis of dementia with Lewy bodies.
After you have read any 3 (to earn 1 hour of category 1 CME credit) or all (to earn 3 hours of credit) of these articles, please complete the CME Evaluation Form.
Archives of Neurology Reader's Choice: Continuing Medical Education. Arch Neurol. 2001;58(3):523-525. doi:10.1001/archneur.58.3.523